the course of events
12 The form and manner of distribution of the opt-out notice was first discussed at a hearing on 29 June 2001. At that time the pleadings did not specifically state that Group Members included deceased persons who had had the Pacemaker implanted. The parties jointly supported giving a notice to Group Members in the form of Annexure A to this Judgment. Senior counsel for the applicant supported the proposal that the notice be sent to the Group Members by ordinary mail by reference to evidence suggesting that the cost of this form of notice would only be about $1,000, compared with about $25,000 if newspaper and television advertisements were to be placed nationally. The evidence also indicated that the respondents maintained a database comprising the names and addresses of persons in whom the Pacemaker had been inserted and that this database was "reasonably current".
13 At the hearing, I expressed concern that a notice in the form of Annexure A, despite the authors' intentions, might induce unnecessary anxiety in some Group Members. In particular, I suggested that the first paragraph might actually alarm some recipients of the notice or their families, and I thought that some of the other language could be simplified. I presented an amended version of the notice to the parties for their consideration. The matter was then adjourned until 4 July 2001 to enable the parties to obtain further instructions and to address the concerns I had expressed.
14 At the hearing on 4 July 2001, counsel for the respondent read an affidavit which recorded that the average age of Group Members was 78 years. The affidavit also recorded the following information concerning the notification of a "hazard alert" to patients who had received a Pacemaker:
"(a) a hazard alert dated 5 June 2000 was prepared by Cardiac Rhythm Solutions in conjunction with the Therapeutic Goods Administration, in relation to the pacemakers the subject of these proceedings (respectively 'the Hazard Alert' and 'the pacemakers');
(b) patient registration information was forwarded to Cardiac Rhythm Solutions by implanting hospitals at the time of implantation of the pacemakers, and this information included details of the patient's name, the names of the implanting and follow-up doctors and the implanting hospital ('the patient registration information');
(c) from information obtained from the patient registration information, copies of the Hazard Alert were hand-delivered, or sent by ordinary mail or facsimile, by Cardiac Rhythms Solutions' sales staff to follow-up doctors and persons in charge of major hospitals with cardiac clinics;
(d) in addition Cardiac Rhythm Solutions identified specific implanting doctors who were responsible persons in charge of pacemakers at specified institutions. Copies of the Hazard Alert were also hand-delivered, or sent by ordinary mail or facsimile, by Cardiac Rhythm Solutions to these specified implanting doctors;
(e) product specialists from each State have confirmed to Cardiac Rhythm Solutions that copies of the Hazard Alert were received by the follow-up doctors, the persons in charge of major hospitals with cardiac clinics and the specified implanting doctors; and
(f) the copies of the Hazard Alert sent to the doctors and clinics attached a list of patients under the particular doctors' care (for implant or follow-up) or as having been under the care of particular clinics, as relevant."
15 The reference to the average age of Group Members prompted me to raise two further questions with the parties:
(i) The first was whether any effort had been made by the parties to identify those Group Members who had died. I was concerned, inter alia, that the relatives of a deceased Group Member should not be exposed to unnecessary distress by a letter addressed to the deceased person as though he or she were still alive.
(ii) The second was whether the applicant intended to include the estates of Group Members as represented parties in the proceedings.
Mr Bannon SC, who appeared for the applicant, answered the first question, in substance, in the negative. After seeking instructions, he answered the second question in the affirmative, but acknowledged that the third amended statement of claim would have to be further amended to make this clear. Following further discussion about additional inquiries the parties could make, especially in relation to those Group Members who may have died, the matter was further adjourned until 17 July 2001.
16 At the hearing on 17 July 2001, the applicant sought leave to file a fourth amended application and a fourth amended statement of claim. Counsel for the respondents requested time to consider the proposed amendments but has since advised the Court that there is no objection to the filing of the amended pleadings. The application is now said to be brought by the applicant on his own behalf and on behalf of persons referred to in [1] above, including the legal personal representatives of the estate of deceased persons who had a Pacemaker surgically implanted in Australia.
17 At the hearing, the applicant handed up a further amended version of the proposed notice, which incorporated references to the fact that Group Members include the legal representatives of the estates of deceased persons who had the Pacemaker implanted in Australia. Some further minor changes were suggested and adopted at that hearing. Mr Bannon also indicated that the applicant now proposed that notice should be given to Group Members by registered mail rather than ordinary mail.
18 At the same hearing, the respondent read an affidavit which recorded that Medtel had been notified of the deaths of twenty-three Group Members. Medtel had become aware of some deaths because surgeons who had removed a Pacemaker upon the death of a patient had on occasions returned the device to the distributor. In addition, Medtel had been notified of other deaths through product specialists who had become aware that some Group Members had died in the course of delivering the hazard alert to doctors and hospitals. The affidavit pointed out that, because there is no system in place by which Medtel is notified of the deaths of all recipients of Pacemakers, the information available to it concerning deceased recipients is necessarily incomplete. I was informed from the Bar table that all of the twenty-three deceased Group Members whose names were known were from Victoria.
19 The parties relied on joint written submissions in which they contended that there was no suitable means of ascertaining which other Group Members, if any, had died. They asserted in the submissions that searches at State and Territory Registries of Births, Deaths and Marriages "would be extremely expensive, cumbersome and time consuming". This assertion was apparently based upon the fact that a separate search must be conducted by name for each deceased person and, in some States and Territories, a fee of $17 to $29 is payable in respect of each search. Furthermore, in New South Wales and South Australia, persons other than a deceased's next of kin or their agents lack standing to conduct a search. The joint submission further asserted that it would be "expensive, cumbersome and time consuming" to conduct searches in the Probate Divisions of the Supreme Courts of the States and Territories. This was said to be the case because search fees are payable in some States or Territories, while elsewhere the search will not disclose the details of the executors or of the deceased's last address. In order to obtain this additional information, another paid search is required.
20 The joint submission concluded with the observation that the parties were unable to suggest a time and cost effective mechanism which would result in the certain identification of all deceased recipients of Pacemakers and the names and addresses of the executors of their estates.
21 Despite the terms of the joint submission, discussion took place concerning the feasibility of further inquiries being made in order to identify deceased Group Members and the executors or administrators of their estates. The parties agreed to explore this question further. They subsequently forwarded to the Court an "agreed protocol". That protocol, subject to minor editorial changes, is as follows:
1. The field staff of the first respondent contact each of the institutions and medical practitioners to whom the Pacemakers were supplied, seeking information in relation to the current status of the patients in whom a Pacemaker was implanted.
2. The respondents' solicitors provide to the applicant's solicitors by 15 August 2001, the name, last known address, date of birth and approximate date of death of any Group Members known to be deceased.
3. The applicant's solicitors undertake a search in the Probate Division of the Supreme Court of the State or Territory in which any deceased Group Member last resided, where such searches are available to the public, by 22 August 2001.
4. Where the applicant's solicitors are able to identify the executor or administrator of the estate of the deceased Group Member, the envelope containing the opt out notice shall be addressed and sent by the applicant's solicitors to that executor or administrator.
5. Where the applicant's solicitors are unable to identify the executor or administrator of the estate of the deceased Group Member, the applicant's solicitors shall address the envelope containing the opt out notice to "The Estate of [name of deceased Group Member]".